Stericycle Past Earnings Performance

Past criteria checks 0/6

Stericycle has been growing earnings at an average annual rate of 64.6%, while the Commercial Services industry saw earnings growing at 29.3% annually. Revenues have been declining at an average rate of 5.3% per year.

Key information

64.6%

Earnings growth rate

64.9%

EPS growth rate

Commercial Services Industry Growth	27.5%
Revenue growth rate	-5.3%
Return on equity	-0.8%
Net Margin	-0.7%
Last Earnings Update	31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Stericycle makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

LSE:0L9O Revenue, expenses and earnings (USD Millions)
Date	Revenue	Earnings	G+A Expenses
31 Mar 24	2,640	-19	696
31 Dec 23	2,659	-21	707
30 Sep 23	2,678	-4	676
30 Jun 23	2,715	22	620
31 Mar 23	2,725	81	698
31 Dec 22	2,705	56	707
30 Sep 22	2,692	7	707
30 Jun 22	2,650	-87	700
31 Mar 22	2,643	-68	686
31 Dec 21	2,647	-28	716
30 Sep 21	2,646	38	634
30 Jun 21	2,633	23	631
31 Mar 21	2,559	-11	620
31 Dec 20	2,676	-57	730
30 Sep 20	2,820	-325	677
30 Jun 20	3,016	-303	698
31 Mar 20	3,264	-329	753
31 Dec 19	3,309	-347	854
30 Sep 19	3,362	-446	810
30 Jun 19	3,384	-369	784
31 Mar 19	3,421	-312	816
31 Dec 18	3,486	-253	1,043
30 Sep 18	3,521	148	826
30 Jun 18	3,549	166	812
31 Mar 18	3,583	-9	814
31 Dec 17	3,581	23	840
30 Sep 17	3,599	-47	987
30 Jun 17	3,607	-21	1,025
31 Mar 17	3,581	165	965
31 Dec 16	3,562	178	777
30 Sep 16	3,544	236	715
30 Jun 16	3,373	244	661
31 Mar 16	3,197	295	605
31 Dec 15	2,986	257	594
30 Sep 15	2,775	269	506
30 Jun 15	2,724	282	495
31 Mar 15	2,649	276	482
31 Dec 14	2,556	326	434
30 Sep 14	2,447	322	428
30 Jun 14	2,313	320	408
31 Mar 14	2,199	316	384
31 Dec 13	2,143	311	380
30 Sep 13	2,079	303	359
30 Jun 13	2,024	288	353

Quality Earnings: 0L9O is currently unprofitable.

Growing Profit Margin: 0L9O is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 0L9O is unprofitable, but has reduced losses over the past 5 years at a rate of 64.6% per year.

Accelerating Growth: Unable to compare 0L9O's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0L9O is unprofitable, making it difficult to compare its past year earnings growth to the Commercial Services industry (17.2%).

Return on Equity

High ROE: 0L9O has a negative Return on Equity (-0.77%), as it is currently unprofitable.

Stericycle Past Earnings Performance

Past criteria checks 0/6

Key information

Recent past performance updates

First quarter 2024 earnings released: EPS: US$0.14 (vs US$0.12 in 1Q 2023)

Full year 2023 earnings released: US$0.23 loss per share (vs US$0.61 profit in FY 2022)

Third quarter 2023 earnings released: EPS: US$0.022 (vs US$0.30 in 3Q 2022)

Stericycle, Inc. Reports Impairment Changes for the Second Quarter Ended June 30, 2023

Second quarter 2023 earnings released: US$0.54 loss per share (vs US$0.11 profit in 2Q 2022)

First quarter 2023 earnings released: EPS: US$0.12 (vs US$0.15 loss in 1Q 2022)

Recent updates

First quarter 2024 earnings released: EPS: US$0.14 (vs US$0.12 in 1Q 2023)

Stericycle, Inc., Annual General Meeting, May 21, 2024

Full year 2023 earnings released: US$0.23 loss per share (vs US$0.61 profit in FY 2022)

New major risk - Financial position

Third quarter 2023 earnings released: EPS: US$0.022 (vs US$0.30 in 3Q 2022)

Stericycle, Inc. Reports Impairment Changes for the Second Quarter Ended June 30, 2023

Second quarter 2023 earnings released: US$0.54 loss per share (vs US$0.11 profit in 2Q 2022)

Enviri Corporation Reaches an Amicable Agreement with Stericycle, Inc

Executive VP & Chief People Officer recently bought US$309k worth of stock

Stericycle, Inc. Approves the Election of Victoria L. Dolan as Director

First quarter 2023 earnings released: EPS: US$0.12 (vs US$0.15 loss in 1Q 2022)

Director recently bought US$287k worth of stock

Full year 2022 earnings released: EPS: US$0.61 (vs US$0.30 loss in FY 2021)

Now 24% undervalued

Insufficient new directors

Stericycle, Inc. Appoints Naren K. Gursahaney to the Board of Directors, Effective January 1, 2023

Insufficient new directors

Infomedia Group, Inc. acquired Stericycle Communication Solutions, Inc. from Stericycle, Inc. (NasdaqGS:SRCL) for $45 million.

Insufficient new directors

Second quarter 2022 earnings released: EPS: US$0.11 (vs US$0.32 in 2Q 2021)

Insufficient new directors

Insufficient new directors

First quarter 2022 earnings released: US$0.15 loss per share (vs US$0.28 profit in 1Q 2021)

Stericycle, Inc., Annual General Meeting, May 26, 2022

Stericycle, Inc. Announces New Safeshield™ Medical Waste Containers

High number of new directors

Stericycle, Inc. Provides Earnings Guidance for the Full-Year 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

High number of new directors

High number of new directors

Third quarter 2021 earnings released: US$0.72 loss per share (vs US$0.89 loss in 3Q 2020)

High number of new directors

Second quarter 2021 earnings released: EPS US$0.32 (vs US$0.049 loss in 2Q 2020)

High number of new directors

First quarter 2021 earnings released: EPS US$0.28 (vs US$0.22 loss in 1Q 2020)

Full year 2020 earnings released: US$0.63 loss per share (vs US$3.81 loss in FY 2019)

Revenue beats expectations

Stericycle, Inc.(NasdaqGS:SRCL) dropped from FTSE All-World Index (USD)

Revenue & Expenses Breakdown

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies